Treatment-resistant Churg-Strauss syndrome: progression after five years using rituximab

Nefrologia. 2013;33(5):737-9. doi: 10.3265/Nefrologia.pre2013.May.12101.
[Article in English, Spanish]
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal, Murine-Derived / therapeutic use*
  • Biopsy
  • Churg-Strauss Syndrome / drug therapy*
  • Churg-Strauss Syndrome / immunology
  • Churg-Strauss Syndrome / therapy
  • Combined Modality Therapy
  • Cyclophosphamide / adverse effects
  • Cyclophosphamide / pharmacology
  • Cyclophosphamide / therapeutic use
  • Disease Progression
  • Drug Resistance
  • Glomerulonephritis / etiology
  • Glomerulonephritis / pathology
  • Glomerulonephritis / therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney / pathology
  • Male
  • Methylprednisolone / pharmacology
  • Methylprednisolone / therapeutic use
  • Plasmapheresis
  • Prednisone / pharmacology
  • Prednisone / therapeutic use
  • Remission Induction
  • Renal Dialysis
  • Rituximab

Substances

  • Antibodies, Monoclonal, Murine-Derived
  • Immunosuppressive Agents
  • Rituximab
  • Cyclophosphamide
  • Prednisone
  • Methylprednisolone